Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia

Psychological Medicine

Volumn 27, Issue 6, 1997, Pages 1303-1310

  Scully, P J ^b   Coakley, G ^b   Kinsella, A ^b   Waddington, J L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; FEMALE; HUMAN; IRELAND; MALE; MENTAL DISEASE; PSYCHOSIS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COGNITION DISORDERS; COHORT STUDIES; EPISODE OF CARE; FRONTAL LOBE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; IRELAND; LONGITUDINAL STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0030814895     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291797005722     Document Type: Article

References (49)

1. Arnold, S. E., Gur, R. E., Shapiro, R. M., Fisher, K. R., Moberg, P. J., Gibney, M. R., Gur, R. C., Blackwell, P. & Trojanowski, J. Q. (1995). Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. American Journal of Psychiatry 152, 731-737.
2. Baum, K. M. & Walker, E. F. (1995). Childhood behavioural precursors of adult symptom dimensions in schizophrenia. Schizophrenia Research 16, 111-120.
3. Bilder, R. M., Lipschutz-Broch, L., Reiter, G., Geisler, S. H., Mayerhoff, D. I. & Lieberman, J. A. (1992). Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophrenia Bulletin 18, 437-448.
4. Crow, T. J., MacMillan, J. F., Johnson, A. L. & Johnstone, E. C. (1986). A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry 148, 120-127.
5. Davidson, M., Harvey, P. D., Powchik, P., Parrella, M., White, L., Knobler, H. Y., Losonczy, M. F., Keefe, R. S. E., Katz, S. & Frecska, E. (1995). Severity of symptoms in chronically institutionalised geriatric schizophrenic patients. American Journal of Psychiatry 152, 197-207.
6. David, J. M. & Andriukaitis, S. (1986). The natural course of schizophrenia and effective maintenance drug treatment. Journal of Clinical Psychopharmacology 6, 2S-10S.
7. Done, D. J., Crow, T. J., Johnstone, E. C. & Sacker, A. (1994). Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. British Medical Journal 309, 699-703.
8. Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A. & Winokur, G. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 57-63.
9. Fenton, W. S. & McGlashan, T. H. (1994). Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. American Journal of Psychiatry 151, 351-356.
10. Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975). 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
11. Goldberg, T. E. & Gold, J. M. (1995). Neurocognitive deficits in schizophrenia. In Schizophrenia (ed. S. R. Hirsch and D. R. Weinberger), pp. 146-162. Blackwell: Oxford.
12. Harvey, P. D., White, L., Parrella, M., Putnam, K. M., Kincaid, M. M., Powchik, P., Mohs, R. C. & Davidson, M. (1995). The longitudinal stability of cognitive impairment in schizophrenia. British Journal of Psychiatry 166, 630-633.
13. Heaton, R., Paulsen, J. S., McAdams, L. A., Kuck, J., Zisook, S., Braff, D., Harris, M. J. & Jeste, D. V. (1994). Neuropsychological deficits in schizophrenia. Archives of General Psychiatry 51, 469-476.
14. Hegarty, J. D., Baldessarini, R. J., Tohen, M., Waternaux, C. & Oepen, G. (1994). One hundred years of schizophrenia: a meta-analysis of the outcome literature. American Journal of Psychiatry 151, 1409-1416.
15. Hoff, A. L., Riordan, H., O'Donnell, D. W., Morris, L. & DeLisi, L. E. (1992). Neuropsychological functioning in first episode schizophreniform patients. American Journal of Psychiatry 149, 898-903.
16. Husted, J. A., Beiser, M. & Iacono, W. G. (1992). Negative symptoms and the early course of schizophrenia. Psychiatry Research 43, 215-222.
17. Hyde, T. M., Nawroz, S., Goldberg, T. E., Bigelow, L. B., Strong, D., Ostrem, J. L., Weinberger, D. R. & Kleinman, J. E. (1994). Is there a cognitive decline in schizophrenia? A cross-sectional study. British Journal of Psychiatry 164, 494-500.
18. Jones, P., Rodgers, B., Murray, R. & Marmot, M. (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398-1402.
19. Kane, J. M. (1996). Schizophrenia. New England Journal of Medicine 334, 34-41.
20. Kay, S. R., Fiszbein, A. & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
21. Kelley, M. E., Gilbertson, M., Mouton, A. & Van Kammen, D. P. (1992). Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients. American Journal of Psychiatry 149, 1543-1548.
22. Kraepelin, E. (1919). Dementia Praecox and Paraphrenia (translated by R. M. Barclay). Livingstone: Edinburgh.
23. Loebel, A. D., Lieberman, J. A., Alvir, J. M. J., Mayerhoff, D. E., Geisler, S. H. & Szymanski, S. R. (1992). Duration of psychosis and outcome in first episode schizophrenia. American Journal of Psychiatry 149, 1183-1188.
24. McEvoy, J. P., Schooler, N. R. & Wilson, W. H. (1991). Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacology Bulletin 27, 97-101.
25. McGlashan, T. H. & Fenton, W. S. (1992). The positive-negative distinction in schizophrenia: review of natural history validators. Archives of General Psychiatry 49, 63-72.
26. McGlashan, T. H. & Fenton, W. S. (1993). Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin 19, 71-84.
27. Mayerhoff, D. I., Loebel, A. D., Alvir, J. M. J., Szymansk, S. R., Geisler, S. H., Borenstein, M. & Lieberman, J. A. (1994). The deficit state in first-episode schizophrenia. American Journal of Psychiatry 151, 1417-1422.
28. Moller, H. J. & von Zerssen, D. (1995). Course and outcome of schizophrenia. In Schizophrenia (ed. S. R. Hirsch and D. R. Weinberger), pp. 106-127. Blackwell: Oxford.
29. Murray, R. M. & Lewis, S. W. (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal 295, 681-681.
30. O'Callaghan, E., Buckley, P., Madigan, C., Redmond, O., Stack, J. P., Kinsella, A., Larkin, C., Ennis, J. T. & Waddington, J. L. (1996). The relationship of minor physical anomalies and other putative indices of neurodevelopmental disturbance in schizophrenia to abnormalities of cerebral structure on MRI. Biological Psychiatry 38, 516-524.
31. Putnam, K. M., Harvey, P. D., Parrella, M., White, L., Kincaid, M., Powchik, P. & Davidson, M. (1996). Symptom stability in geriatric chronic schizophrenic inpatients: a one-year follow-up study. Biological Psychiatry 39, 92-99.
32. Royall, D. R., Mahurin, R. K. & Gray, K. F. (1992). Bedside assessment of executive cognitive impairment: the Executive Interview. Journal of the American Geriatric Society 40, 1221-1226.
33. Royall, D. R., Mahurin, R. K., True, J. E., Anderson, B., Brock, I. P., Freeburger, L. & Miller, A. (1993). Executive impairment among the functionally dependent: comparisons between schizophrenic and elderly subjects. American Journal of Psychiatry 150, 1813-1819.
34. Saykin, A. J., Shtasel, D. L., Gur, R. E., Kester, D. B., Mozley, L. H., Stafiniak, P. & Gur, R. C. (1994). Neuropsychological deficits in neuroleptic-naive patients with first-episode schizophrenia. Archives of General Psychiatry 51, 124-131.
35. Scully, P. J., Coakley, G., Kinsella, A. & Waddington, J. L. (1997). Executive (frontal) dysfunction and negative symptoms in schizophrenia: apparent gender differences in 'static' v. 'progressive' profiles. British Journal of Psychiatry 171, 154-188.
36. Szymanski, S. R., Cannon, T. D., Gallacher, F., Erwin, R. J. & Gur, R. E. (1996). Course of treatment response in first episode and chronic schizophrenia. American Journal of Psychiatry 153, 519-525.
37. Wadddington, J. L. (1993). Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531-536.
38. Waddington, J. L. (1995). The clinical psychopharmacology of antipsychotic drugs in schizophrenia. In Schizophrenia (ed. S. R. Hirsch and D. R. Weinberger), pp. 341-357. Blackwell: Oxford.
39. Waddington, J. L. & Buckley, P. F. (1996). The Neurodevelopmental Basis of Schizophrenia. Austin: Landes.
40. Waddington, J. L. & Youssef, H. A. (1996). Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine 25, 849-857.
41. Waddington, J. L., Youssef, H. A., Dolphin, C. & Kinsella, A. (1987). Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Archives of General Psychiatry 44, 907-912.
42. Waddington, J. L., Youssef, H. A. & Kinsella, A. (1990). Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine 20, 835-842.
43. Waddington, J. L., Youssef, H. A. & Kinsella, A. (1995). Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychological Medicine 25, 849-847.
44. Waddington, J. L., Scully, P. J. & Youssef, H. A. (1997). Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. Schizophrenia Research 23, 107-118.
45. Walker, F., Savoie, T. & Davis, D. (1994). Neuromotor precursors of schizophrenia. Schizophrenia Bulletin 20, 441-451.
46. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44, 660-669.
47. Weinberger, D. R. (1995). Schizophrenia: from neuropathology to neurodevelopment. Lancet 346, 552-557.
48. Wyatt, R. J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 17, 325-351.
49. Wyatt, R. J. (1995). Early intervention for schizophrenia: can the course of the illness be altered? Biological Psychiatry 38, 1-3.